share_log

Needham Maintains Buy on Merit Medical Systems, Lowers Price Target to $81

Needham Maintains Buy on Merit Medical Systems, Lowers Price Target to $81

Needham维持对Merit Medical Systems的买入,将目标价下调至81美元
Benzinga ·  2023/10/27 06:59

Needham analyst Mike Matson maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and lowers the price target from $96 to $81.

Needham分析师Mike·马特森维持纳斯达克(Sequoia Capital:MMSI)的买入评级,并将目标价从96美元下调至81美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发